SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BONE MEDICAL LIMITED (BNE)

Former Name ASX

SHARE PRICES

(updated weekly)

Former (or subsequent) names

 FROMTO
BOTANIX PHARMACEUTICALS LTD07/07/2016
BONE MEDICAL LIMITED20/08/200407/07/2016
REVENIR LIMITED22/01/200420/08/2004
ALIQUOT ASSET MANAGEMENT LIMITED20/08/200122/01/2004
AERODATA HOLDINGS LIMITED20/08/2001

Shareholder links

Our website ranking of BNE: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Registry Services Level 5 126 Phillip Street Sydney NSW 2000

Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
Fax :
RegistryWebsite RegistryEmail

Company details

Address: Ground Floor 16 Ord Street West Perth WA 6005
Tel:  +61 (0) 8 9482 0580 Fax: +61 (0) 8 9482 0505

Date first listed: 24/01/1985
Company Secretary: Brett Tucker
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biopharmaceutical development projects for the treatment of bone and joint disease

name changed to Botanix Pharmaceuticals Ltd

07/07/2016

The company is pleased to announce the completion of the transaction to acquire the entire issued capital of Botanix Pharmaceuticals, Inc. by way of a merger to become Botanix Pharmaceuticals Limited. The agreements between the Company and the shareholders of Botanix have been completed. In addition, the Company has raised $3.5 million under the public offer pursuant to the Prospectus and Supplementary Prospectus.

04/07/2016

we understand that on or about this date the company consolidated its shares 1000 for 3333

28/06/2016

we understand that on or about this date the company consolidated its shares 1000 for 3333

28/06/2016

The company is pleased to announce that the Prospectus Offer for the acquisition of Botanix Pharmaceuticals has closed heavily oversubscribed following strong support from investors.

27/06/2016

The company issues a supplementary prospectus intended to be read with the prospectus dated 13 May 2016, issued by Bone Medical Limited.

24/06/2016

The company announces the results of its meeting.

14/06/2016

The securities of Bone Medical Limited ("Company") will be suspended from official quotation immediately, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature and scale of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules.

14/06/2016

we understand that on or about this date the company consolidated its shares 1 for 50

24/01/2014

The suspension of trading in the securities of Bone Medical Limited (the "Company") will be lifted prior to the commencement of trading tomorrow, Thursday 29 August 2013, pursuant to Listing Rule 17.9, following the payment of annual listing fees for the year ending 30 June 2014 by the Company. Security Code: BNE

28/08/2013

Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Thursday 22 August 2013 is to be suspended from official quotation before the commencement of trading on Friday 23 August 2013. The company has failed to pay to ASX Limited their annual listing fees in respect of the year ending 30 June 2014 and consequently will be suspended from quotation immediately.

23/08/2013

securities reinstated to quotation

08/03/2011

suspended from quotation following failure to lodge its half yearly financial report

01/03/2011

securities reinstated to quotation

19/12/2007

securities suspended from quotation pending an announcement

13/12/2007

we understand that on or about this date the company consolidated its shares 1 for 4

23/08/2004

name changed from Revenir Limited

20/08/2004

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    10/04/2015Robert Towner-2,500,000$0.013$32,440

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Robert TownerNon Exec Chairman28/01/2014
    Graham GriffithsNon Exec Chairman01/07/2016
    Peter YoungManaging Director, CEO05/04/2011
    Matt CallahanExecutive Director01/07/2016
    William BoschExecutive Director01/07/2016

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    John HannafordNon Exec Director28/01/201401/07/2016
    Phillip WingateNon Exec Director27/11/201401/07/2016
    Roger NewNon Exec Director02/06/200527/11/2014
    Leon IvoryDirector16/11/200524/01/2014
    Peter BrooksDirector25/07/200724/01/2014

    Date of first appointment, title may have changed.